In an open trial, eight patients with psoriasis took part in a four-month study to evaluate the effect of a new oral synthetic retinoid Ro-10-9359 (Tigason). All patients improved on the treatment, although one had side effects severe enough to force dosage reduction with less satisfactory control.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
ro-10-9359 tigason
8
systemic treatment
4
treatment psoriasis
4
psoriasis oral
4
oral retinoic
4
retinoic acid
4
acid derivative
4
derivative ro-10-9359
4
tigason open
4
open trial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!